Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIORDEX: Dexamethasone vs IVIg + Prednisone for ITP
NCT04968899Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in immune thrombocytopenia (ITP), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2022; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04968899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04968899.